Psoriasis specialists evaluate strategies for integrating emerging therapies into existing treatment protocols and conclude by addressing persistent gaps in current psoriasis management approaches.
UCB Presents 4-Year Data on Bimekizumab for Plaque Psoriasis
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Psoriasis within the US Hispanic Population: What Can Be Done to Diversify Clinical Data?
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
‘Next-Generation TYK2 Inhibitor’: Insights into Zasocitinib
FDA Accepts Roflumilast Foam sNDA for Scalp and Body Psoriasis